Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation

The present study was to investigate whether sulforaphane (SFN) can prevent diabetic nephropathy in type 1 diabetic mouse model induced by multiple low-dose streptozotocin. Diabetic and age-matched control mice were given SFN at 0.5 mg/kg body weight daily for 3 months. At the end of 3-month SFN tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Wenpeng, Bai, Yang, Miao, Xiao, Luo, Ping, Chen, Qiang, Tan, Yi, Rane, Madhavi J., Miao, Lining, Cai, Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461640/
https://www.ncbi.nlm.nih.gov/pubmed/23050040
http://dx.doi.org/10.1155/2012/821936

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461640/
https://www.ncbi.nlm.nih.gov/pubmed/23050040
http://dx.doi.org/10.1155/2012/821936

Ejemplares similares